Vivo Opportunity Fund Holdings, L.P. and its related entities have filed a Schedule 13G, reporting beneficial ownership of 2,864,346 shares of AN2 Therapeutics, Inc. Common Stock, representing 8.0% of the outstanding shares. Vivo Opportunity, LLC, as the general partner, shares this beneficial ownership. Additionally, ...

Linden Capital L.P., along with affiliated entities and individuals including Linden GP LLC, Linden Advisors LP, and Siu Min (Joe) Wong, has reported beneficial ownership of 1RT Acquisition Corp. Class A ordinary shares. As of March 5, 2026, Linden Capital L.P. and Linden GP LLC each beneficially own 973,096 shares, re...

Daniel Kaufman has acquired a 5.12% stake in Arq, representing 2,191,278 shares. This filing, dated March 12, 2026, with an event date of March 11, 2026, indicates that Kaufman holds sole voting and dispositive power over these shares. The principal business office for Kaufman is located in San Juan, Puerto Rico, while...

Asymmetry Point LP, along with its general partner Asymmetry Point Capital LLC and fund manager Mr. Aviv Argaman, has reported acquiring 610,000 shares of NexGel, Inc. common stock. This acquisition represents a 7.49% ownership stake in the company, based on a total of 8,143,133 shares outstanding as of November 12, 20...

Tibbs Isaiah has acquired beneficial ownership of 1,830,007 shares of CERO Therapeutics Holdings, Inc. common stock, representing 8.67% of the outstanding shares. This filing, a Schedule 13G, indicates that the securities were not acquired for the purpose of influencing or changing the control of the issuer. The acquis...

Fulgur Frontier Capital LP, a Bahamian limited partnership, has acquired a 12.2% ownership in Cantor Equity Partners I, Inc., a Cayman Islands exempted company. This translates to 2,500,000 Class A ordinary shares, with Fulgur Frontier holding sole voting and dispositive power over these shares. The acquisition was mad...

Capitalink Ltd. has acquired a 5.04% ownership in Viewbix Inc., amounting to 672,007 shares. This filing, designated as SCHEDULE 13G, indicates that the shares were acquired on March 4, 2026, with the filing date being March 12, 2026. The reporting person, Capitalink Ltd., has sole voting and dispositive power over the...

Valiant Capital Management, L.P. (VCM), along with VCM LLC and Christopher R. Hansen, has filed a Schedule 13G, reporting beneficial ownership of 16,212,903 shares of Core Scientific, Inc. common stock. This represents 5.1% of the outstanding shares, based on a total of 315,332,655 shares as of February 26, 2026. VCM a...

Dr. Reddy's Laboratories, Inc., along with its parent companies Dr. Reddy's Laboratories SA and Dr. Reddy's Laboratories Limited, has acquired a beneficial ownership of 2,272,727 shares of Coya Therapeutics, Inc. Common Stock. This represents a 9.7% ownership stake in the company. The acquisition was reported on a Sche...

Diveroli Investment Group LLC and Kingbird Ventures LLC, collectively referred to as the Reporting Persons, have filed a Schedule 13G, indicating an aggregate ownership of approximately 9.5% of Vision Marine Technologies Inc.'s outstanding Common Stock as of March 4, 2026. Kingbird Ventures LLC directly holds 119,326 s...

Dr. Reddy's Laboratories, Inc., along with its parent companies Dr. Reddy's Laboratories SA and Dr. Reddy's Laboratories Limited, has acquired a beneficial ownership of 2,272,727 shares of Coya Therapeutics, Inc. Common Stock. This represents a 9.7% ownership stake in the company. The acquisition was reported on a Sche...

Fulgur Frontier Capital LP, a Bahamian limited partnership, has acquired a 12.2% ownership in Cantor Equity Partners I, Inc., a Cayman Islands exempted company. This translates to 2,500,000 Class A ordinary shares, with Fulgur Frontier holding sole voting and dispositive power over these shares. The acquisition was mad...

Daniel Kaufman has acquired a 5.12% stake in Arq, representing 2,191,278 shares. This filing, dated March 12, 2026, with an event date of March 11, 2026, indicates that Kaufman holds sole voting and dispositive power over these shares. The principal business office for Kaufman is located in San Juan, Puerto Rico, while...

Linden Capital L.P., along with affiliated entities and individuals including Linden GP LLC, Linden Advisors LP, and Siu Min (Joe) Wong, has reported beneficial ownership of 1RT Acquisition Corp. Class A ordinary shares. As of March 5, 2026, Linden Capital L.P. and Linden GP LLC each beneficially own 973,096 shares, re...

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has filed a Schedule 13G, indicating a 5.3% ownership in Phathom Pharmaceuticals, Inc. As of March 6, 2026, the total number of shares beneficially owned is 4,178,411. The filing confirms that these securities were not acquir...

Asymmetry Point LP, along with its general partner Asymmetry Point Capital LLC and fund manager Mr. Aviv Argaman, has reported acquiring 610,000 shares of NexGel, Inc. common stock. This acquisition represents a 7.49% ownership stake in the company, based on a total of 8,143,133 shares outstanding as of November 12, 20...

Perea Capital Partners, LP, along with Perea Capital, LP, Perea Capital, LLC, and Omar Musa, collectively hold a beneficial ownership of 3,343,295 shares of Zenvia Inc.'s Class A Common Shares, representing 11.57% of the total outstanding shares. This filing, dated March 12, 2026, is made in accordance with Rule 13d-1(...

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has filed a Schedule 13G, indicating a 5.3% ownership in Phathom Pharmaceuticals, Inc. As of March 6, 2026, the total number of shares beneficially owned is 4,178,411. The filing confirms that these securities were not acquir...

Tibbs Isaiah has acquired beneficial ownership of 1,830,007 shares of CERO Therapeutics Holdings, Inc. common stock, representing 8.67% of the outstanding shares. This filing, a Schedule 13G, indicates that the securities were not acquired for the purpose of influencing or changing the control of the issuer. The acquis...

Valiant Capital Management, L.P. (VCM), along with VCM LLC and Christopher R. Hansen, has filed a Schedule 13G, reporting beneficial ownership of 16,212,903 shares of Core Scientific, Inc. common stock. This represents 5.1% of the outstanding shares, based on a total of 315,332,655 shares as of February 26, 2026. VCM a...

Capitalink Ltd. has acquired a 5.04% ownership in Viewbix Inc., amounting to 672,007 shares. This filing, designated as SCHEDULE 13G, indicates that the shares were acquired on March 4, 2026, with the filing date being March 12, 2026. The reporting person, Capitalink Ltd., has sole voting and dispositive power over the...

Diveroli Investment Group LLC and Kingbird Ventures LLC, collectively referred to as the Reporting Persons, have filed a Schedule 13G, indicating an aggregate ownership of approximately 9.5% of Vision Marine Technologies Inc.'s outstanding Common Stock as of March 4, 2026. Kingbird Ventures LLC directly holds 119,326 s...

Perea Capital Partners, LP, along with Perea Capital, LP, Perea Capital, LLC, and Omar Musa, collectively hold a beneficial ownership of 3,343,295 shares of Zenvia Inc.'s Class A Common Shares, representing 11.57% of the total outstanding shares. This filing, dated March 12, 2026, is made in accordance with Rule 13d-1(...

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed a Schedule 13G regarding their beneficial ownership of Class A Ordinary Shares of A Paradise Acquisition Corp. As of March 4, 2026, they collectively hold 1,081,500 shares, representing 5.3% of the class. This filing ...

Khrom Investments Fund, LP, Khrom Capital Management LLC, and Mr. Eric Khrom have filed a Schedule 13G, reporting beneficial ownership of Acadia Healthcare Company, Inc. common stock. As of March 10, 2026, they collectively own 7,457,311 shares, representing approximately 8.09% of the outstanding shares. Khrom Investme...